Media stories about Senseonics Holdings (NASDAQ:SENS) have trended somewhat positive this week, Accern reports. Accern ranks the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Senseonics Holdings earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave media headlines about the company an impact score of 43.9168410140594 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

A number of research firms have issued reports on SENS. Zacks Investment Research upgraded Senseonics Holdings from a “sell” rating to a “hold” rating in a report on Tuesday, August 15th. Canaccord Genuity restated a “buy” rating on shares of Senseonics Holdings in a report on Thursday, September 28th.

Senseonics Holdings (NASDAQ SENS) traded up 5.03% during trading on Friday, hitting $3.34. The company’s stock had a trading volume of 1,001,915 shares. Senseonics Holdings has a 12 month low of $2.15 and a 12 month high of $3.67. The firm’s market cap is $411.49 million. The firm has a 50 day moving average of $3.12 and a 200 day moving average of $3.12.

Senseonics Holdings (NASDAQ:SENS) last issued its quarterly earnings data on Wednesday, August 9th. The company reported ($0.12) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.13) by $0.01. The business had revenue of $0.81 million during the quarter, compared to the consensus estimate of $0.81 million. Equities research analysts predict that Senseonics Holdings will post ($0.54) earnings per share for the current year.

In other news, COO Mukul Jain sold 11,885 shares of Senseonics Holdings stock in a transaction that occurred on Monday, October 2nd. The stock was sold at an average price of $3.25, for a total value of $38,626.25. The sale was disclosed in a document filed with the SEC, which is available through this link.

ILLEGAL ACTIVITY WARNING: This article was first posted by Watch List News and is the sole property of of Watch List News. If you are reading this article on another domain, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this article can be read at

Senseonics Holdings Company Profile

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Insider Buying and Selling by Quarter for Senseonics Holdings (NASDAQ:SENS)

Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.